This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
A newly developed therapeutic ladder can help guide dermatologists and patients on the use of nonsteroidal treatment options for atopic dermatitis (AD). Nonsteroidal treatment options for AD have rapidly expanded in recent years with the development of phosphodiesterase-4 inhibitors, biologics, and Janus kinase (JAK) inhibitors. Although topical corticosteroids are still considered the first line in AD, adverse effects can occur especially with prolonged usage.
Offering pure natural mineral powder for your clients to use after their skincare treatments is a must. Makeup is an extension of our skincare regimen. Using good quality ingredients will keep the skin looking healthy and radiant. We have a line of pure natural mineral powder that is easy to color match and doesn’t require you to buy a large amount of sku’s.
RP1, an investigational oncolytic immunotherapy, may be an effective treatment option for solid organ transplant (SOT) recipients with advanced non- melanoma skin cancer, according to research presented at the American Association for Cancer Research (AACR) Annual Meeting 2024 in San Diego, CA. Oncolytic immunotherapy uses viruses to target and destroy cancer cells while also stimulating the body’s immune response against the tumor.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content